Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been clinically diagnosed with retinitis pigmentosa or a similar condition where the retina gradually deteriorates over time
- People who are currently using a device called the OkuStim® System for transcorneal electrical stimulation (a treatment that applies mild electrical signals to the eye) as it is intended to be used
- People who have noticed short-term effects on their vision or symptoms after receiving this electrical stimulation treatment
- People who are willing and able to give their informed consent to participate in the study
Who may not be able to join:
- People who have cognitive, psychological, or language difficulties that would make it hard to give informed consent or take part properly in the study
- People who have other eye conditions — such as cataracts, glaucoma, or macular degeneration — that the trial doctor believes could interfere with or confuse the study results
- People who are currently taking part in another clinical trial that could affect this study's results
- People who have serious other health conditions that could put their safety at risk or make it difficult to carry out the study properly
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dr. med. Svenja Deuchler, Augenzentrum Frankfurt Prof. Koch GmbH
Phone: +49 69 7566 8880
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Best-corrected visual acuity; Contrast sensitivity; Retinal sensitivity; Subjective changes in visual performance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.